| Trial ID: | L0356 |
| Source ID: | NCT00858299
|
| Associated Drug: |
Valsartan
|
| Title: |
The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Proteinuria
|
| Interventions: |
DRUG: valsartan
|
| Outcome Measures: |
Primary: The percent change of urinary angiotensinogen excretion between at baseline and at 24 weeks after valsartan treatment., 4 weeks of screening periods + 24 weeks of treatment |
|
| Sponsor/Collaborators: |
Sponsor: Samsung Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
500
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2009-03
|
| Completion Date: |
2011-12
|
| Results First Posted: |
|
| Last Update Posted: |
2009-03-09
|
| Locations: |
Division of Nephrology, Samsung Medical Center, Seoul, 135-710, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00858299
|
